ADAPTIN BIO, INC.
Data quality: 67%
APTN
OTC
Manufacturing
Chemicals
Quick Summary
Key Takeaways
Negative free cash flow of -4.78 M
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
N/A
Current Ratio0.53
Interest Coverage-74.53
Valuation
P/E Ratio
N/A
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Manufacturing sector median (1364 peers)
Peer Comparison
vs Manufacturing sector median (1364 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | — | -1.5 |
| P/B | — | 1.6 |
| ROE % | — | -53.5 |
| Net Margin % | — | -41.5 |
| Rev Growth 5Y % | — | 1.8 |
| D/E | — | 0.3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -5.17 M |
| ROE | N/A | ROA | -391.17% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -4.78 M |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0.53 |
| Interest Coverage | -74.53 | Asset Turnover | N/A |
| Working Capital | -881,078 | Tangible Book Value | -881,078 |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | N/A | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | N/A | ||
| Market Cap | N/A | Enterprise Value | N/A |
| Per Share | |||
| EPS (Diluted TTM) | -0.66 | Revenue / Share | N/A |
| FCF / Share | N/A | OCF / Share | N/A |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 92.46% |
| SBC-Adj. FCF | -5.10 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | — | — | — |
| Net Income | -5.17 M | -161,160.0 | -85,593.0 |
| EPS (Diluted) | -0.66 | -0.03 | -0.02 |
| Gross Profit | — | — | — |
| Operating Income | -5.41 M | -155,374.0 | — |
| EBITDA | — | — | — |
| R&D Expenses | 1.77 M | — | — |
| SG&A Expenses | — | — | — |
| D&A | — | — | — |
| Interest Expense | 72,659.0 | 5,786.0 | — |
| Income Tax | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Total Assets | 619,159.0 | 12,619.0 | 380.0 |
| Total Liabilities | 2.11 M | 286,676.0 | 113,277.0 |
| Shareholders' Equity | -1.49 M | -274,057.0 | -112,897.0 |
| Total Debt | — | — | — |
| Cash & Equivalents | 459,174.0 | — | 380.0 |
| Current Assets | 619,159.0 | 12,619.0 | 380.0 |
| Current Liabilities | 2.11 M | 286,676.0 | 113,277.0 |
{"event":"ticker_viewed","properties":{"ticker":"APTN","listing_kind":"stock","pathname":"/stocks/aptn","exchange":"OTC","country":"US"}}